Titel	Veröffentlichungsdatum	Sprache	Zitate
Diffuse intrinsic pontine glioma: poised for progress	2012/01/01		181
Targeting ECM Disrupts Cancer Progression	2015/10/20		181
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets	2019/09/26		180
Radiation as an immunological adjuvant: current evidence on dose and fractionation	2012/01/01		179
The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis	2014/05/19		178
p53 Family and Cellular Stress Responses in Cancer	2014/10/21		178
4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity	2015/06/08		177
The Aurora B Kinase in Chromosome Bi-Orientation and Spindle Checkpoint Signaling	2015/10/16		176
DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy	2013/01/01		175
Unraveling the Role of Angiogenesis in Cancer Ecosystems	2018/07/02		172
The Dual Role of Cellular Senescence in Developing Tumors and Their Response to Cancer Therapy	2017/11/23		172
Combinations of Immunotherapy and Radiation in Cancer Therapy	2014/11/28		171
Aurora Kinase Inhibitors: Current Status and Outlook	2015/12/21		171
Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function	2014/01/01		170
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology	2013/01/01		169
The FLUKA Code: An Accurate Simulation Tool for Particle Therapy	2016/05/11		169
Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update	2018/06/13		169
Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data	2015/09/22		169
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression	2018/06/12		167
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity	2014/04/10		165
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies	2020/01/22		164
Tumor Targeting via Integrin Ligands	2013/01/01		164
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer	2017/02/22		164
Defining the Role of Solid Stress and Matrix Stiffness in Cancer Cell Proliferation and Metastasis	2018/03/12		163
Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer	2019/07/25		163
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics	2017/11/14		162
YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma	2019/05/03		162
Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology	2019/05/08		161
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics	2019/05/17		160
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies	2014/03/06		160